In last trading session, Olema Pharmaceuticals Inc (NASDAQ:OLMA) saw 0.92 million shares changing hands with its beta currently measuring 2.12. Company’s recent per share price level of $11.23 trading at -$0.32 or -2.77% at ring of the bell on the day assigns it a market valuation of $627.87M. That closing price of OLMA’s stock is at a discount of -58.41% from its 52-week high price of $17.79 and is indicating a premium of 73.29% from its 52-week low price of $3.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.53 million shares which gives us an average trading volume of 806.12K if we extend that period to 3-months.
Olema Pharmaceuticals Inc (NASDAQ:OLMA) trade information
Upright in the red during last session for losing -2.77%, in the last five days OLMA remained trading in the red while hitting it’s week-highest on Tuesday, 03/19/24 when the stock touched $11.23 price level, adding 5.23% to its value on the day. Olema Pharmaceuticals Inc’s shares saw a change of -19.96% in year-to-date performance and have moved -2.77% in past 5-day. Olema Pharmaceuticals Inc (NASDAQ:OLMA) showed a performance of -16.69% in past 30-days. Number of shares sold short was 4.87 million shares which calculate 7.2 days to cover the short interests.
Olema Pharmaceuticals Inc (OLMA) estimates and forecasts
Statistics highlight that Olema Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -6.65% of value to its shares in past 6 months, showing an annual growth rate of -4.67% while that of industry is 12.00. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 24.30% in the current quarter and calculating -16.30% decrease in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -105.28% during past 5 years.
OLMA Dividends
Olema Pharmaceuticals Inc is more likely to be releasing its next quarterly report between May 07 and May 13 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Olema Pharmaceuticals Inc (NASDAQ:OLMA)’s Major holders
Insiders are in possession of 3.97% of company’s total shares while institution are holding 93.55 percent of that, with stock having share float percentage of 97.42%. Investors also watch the number of corporate investors in a company very closely, which is 93.55% institutions for Olema Pharmaceuticals Inc that are currently holding shares of the company. BVF Inc. is the top institutional holder at OLMA for having 9.14 million shares of worth $102.6 million. And as of Dec 30, 2023, it was holding 16.34% of the company’s outstanding shares.
The second largest institutional holder is Paradigm Biocapital Advisors LP, which was holding about 7.9 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 14.14% of outstanding shares, having a total worth of $88.76 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 30, 2023, the former fund manager was holding 1.65 million shares of worth $18.53 million or 2.95% of the total outstanding shares. The later fund manager was in possession of 0.8 million shares on Dec 30, 2023, making its stake of worth around $8.93 million in the company or a holder of 1.42% of company’s stock.
